Neuroscience

The promise of regenerative medicine to treat chronic pain

The use of regenerative medicine to lessen chronic pain holds enormous potential, and the body of evidence to support the practice is growing, said Alexios Carayannopoulos, DO, MPH, DABPMR, chief of the departments of physical ...

Medications

Trial results of new drug for generalized myasthenia gravis

Argenx, a Belgium pharmaceutical company, recently announced that The Lancet Neurology has published pivotal trial results from the Phase 3 ADAPT trial of efgartigimod, an FcRn antagonist, for the treatment of adults living ...

Vaccination

Biden announces Uber, Lyft rides amid July 4 vaccine push

President Joe Biden is highlighting new efforts to encourage Americans to get COVID-19 shots, including free rides to and from vaccination sites from ride-sharing companies Uber and Lyft, as the pace of shots nationally declines ...

Diseases, Conditions, Syndromes

5 strategies to prepare now for the next pandemic

While the world is still reeling from the COVID-19 pandemic, public health and emergency management experts are already preparing for the next one. After all, biologists are certain another dangerous new pathogen will emerge ...

Parkinson's & Movement disorders

Telehealth use up markedly among Parkinson patients

Parkinson disease (PD) symptoms and management practices were markedly affected by COVID-19, according to a study published online Jan. 21 in npj Parkinson's Disease.

page 1 from 15